Olon, global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and generic markets, integrating chemical…
Milan, 10th Maj 2023 – One year after the launch of the International Network for Biocatalysis, an innovative scientific platform…
With Olon investing significantly in its production capacity and technical capabilities, CEO Paolo Tubertini believes the API specialist is well-positioned…
“What we are doing here is beginning the build-out of a high-potency API suite, so that we can get up…
Within the framework of a consolidated and pioneering regulatory strategy, Olon announces that its Rifampicin Drug Master File is eligible…
Milan, Italy, 17 th March 23, 2023 — Olon Group, global leader in the development and production ofactive pharmaceutical ingredients (APIs), integrating…
Olon is pleased to announce the completion of the investment in its Rodano facility to expand the pilot plant capacity…
Milan – Italy, February 20, 2023 – Olon Group and the Politecnico di Milano, Department of Chemistry, Materials and Chemical…
MiKE H. O’Neill, Director, Analytical Chemistry at Olon Ricerca Bioscience LLC, gave a scientific lecture about Analytical Chemistry in Early-Stage…